Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor...

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• Human platelets release transforming growth factor-beta (TGF-beta) upon degranulation.
• This secreted TGF-beta is biologically latent, unable to bind cellular receptors or be immunoprecipitated.
• The latent form suggests masking of the receptor-binding site and other TGF-beta epitopes.

Purpose of the Study:

• To characterize the molecular complex of latent TGF-beta secreted by human platelets.
• To investigate the relationship between platelet-derived latent TGF-beta and serum latent TGF-beta.
• To explore the functional implications of the latent TGF-beta complex in cellular delivery versus serum clearance.

Main Methods:

• Western blot analysis to determine the molecular weight and composition of the platelet TGF-beta complex.
• Gel filtration and chromatographic analysis to assess complex aggregation and binding properties.
• Investigating the binding of latent and activated TGF-beta to alpha-2-macroglobulin (alpha 2M).

Main Results:

• Platelet-secreted latent TGF-beta exists as a 220-235 kDa complex.
• This complex contains mature TGF-beta (25 kDa), precursor sequences (74 kDa), and an unidentified 135 kDa component.
• The latent complex does not bind alpha 2M, but activated TGF-beta does, suggesting a role for alpha 2M in scavenging.
• Latent TGF-beta from various cultured cells is similar to that from platelets.

Conclusions:

• Platelet-derived latent TGF-beta functions as a cellular delivery complex.
• Serum latent TGF-beta, identified as an alpha 2M complex, likely serves as a clearance complex.
• Alpha 2M may scavenge TGF-beta released upon activation of the platelet latent complex, potentially during clotting.